Pharmacokinetic studies of a three-component complex that repurposes the front line antibiotic isoniazid against Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic studies of a three-component complex that repurposes the front line antibiotic isoniazid against Mycobacterium tuberculosis

Published:2017-12 Issue: Volume:107 Page:149-155
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Manning Thomas J.,Wilkerson Kyle,Holder Taylor,Bartley Andrew Carson,Jackson Chelsea,Plummer Sydney,Phillips Dennis,Krajewski Logan,Wylie Greg

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

National Institutes of Health, Department of Health and Human Services

National Science Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference58 articles.

1. History of tuberculosis and drug resistance;Marais;New Engl J Med,2013

2. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis;World Health Organization,2014

3. A note on derivatives of isoniazid, Rifampicin, and pyrazinamide showing activity against resistant Mycobacterium tuberculosis;Nusrath;Chem Biol Drug Des,2016

4. Successful 9-month Bangladesh regimen for multidrug-resistant tuberculosis among over 500 consecutive patients;Aung;Int J Tuberc Lung Dis,2014

5. Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal;Cohen;PLoS Med,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular building blocks and nutrients as a novel cancer treatment;Invention Disclosure;2024

2. In vitro antimycobacterial activity and interaction profiles of diarylthiourea-copper (II) complexes with antitubercular drugs against Mycobacterium tuberculosis isolates;Tuberculosis;2023-12

3. Inhalation Therapy in Pulmonary Tuberculosis;Integrated Science;2023

4. Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones;Journal of Medicinal Chemistry;2022-05-03

5. Chiral Recognition R- and RS- of New Antifungal: Complexation/Solubilization/Dissolution Thermodynamics and Permeability Assay;Pharmaceutics;2022-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3